ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soubani, A. O.
Right arrow Articles by Uberti, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soubani, A. O.
Right arrow Articles by Uberti, J. P.
Eur Respir J 2007; 29:1007-1019
Copyright ©ERS Journals Ltd 2007

Bronchiolitis obliterans following haematopoietic stem cell transplantation

A. O. Soubani1 and J. P. Uberti2

1 Division of Pulmonary and Critical Care Medicine, and 2 Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Center and Wayne State University School of Medicine, Detroit, MI, USA.

CORRESPONDENCE: A. O. Soubani, Division of Pulmonary, Critical Care and Sleep Medicine, Harper University Hospital, 3990 John R-3 Hudson, Detroit, MI 48201, USA. Fax: 1 3139930562. E-mail: asoubani{at}med.wayne.edu

Keywords: Bone marrow transplantation, bronchiolitis

Received: April 17, 2006
Accepted October 24, 2006

The aim of the present article is to review the available clinical data on bronchiolitis obliterans following haematopoietic stem cell transplantation (HSCT).

The data sources used were the Medline database and references from the identified articles related to bronchiolitis obliterans, noninfectious pulmonary complications and HSCT.

HSCT is an important treatment for a variety of malignant and nonmalignant conditions. However, the procedure is limited by significant complications that may involve every organ of the body. Pulmonary complications are seen in 40–60% of HSCT recipients. The recent advances in prophylaxis and treatment of infectious complications have increased the significance of late noninfectious pulmonary conditions.

Currently, bronchiolitis obliterans is one of the most challenging pulmonary complications facing clinicians who are taking care of haematopoietic stem cell transplantation recipients. This article reviews the clinical and pathological features of this condition, sheds some light on potential mechanisms of pathogenesis, and discusses the available management options.




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
R. G. Crystal, S. H. Randell, J. F. Engelhardt, J. Voynow, and M. E. Sunday
Airway Epithelial Cells: Current Concepts and Challenges
Proceedings of the ATS, September 15, 2008; 5(7): 772 - 777.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.